Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

NCT00391196 ·Status: TERMINATED ·Phase: PHASE3

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 ·Status: COMPLETED ·Phase: PHASE2

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ·Status: COMPLETED ·Phase: PHASE3

A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

NCT00799006 ·Status: COMPLETED ·Phase: PHASE1

A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.

NCT00349635 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study of SHP626 in Overweight and Obese Adults

NCT02287779 ·Status: COMPLETED ·Phase: PHASE1

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

NCT00472836 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test Different Doses of BI 456906 in Patients With Obesity

NCT03591718 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)

NCT00384605 ·Status: TERMINATED ·Phase: PHASE3

Taldefgrobep Alfa in Adults With Overweight and Obesity

NCT07281495 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

NCT02354976 ·Status: COMPLETED ·Phase: PHASE2

Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

NCT01133210 ·Status: COMPLETED ·Phase: PHASE1

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

NCT04616339 ·Status: COMPLETED ·Phase: PHASE1

A Study of MK0364 in Obese Patients (0364-014)

NCT00131391 ·Status: TERMINATED ·Phase: PHASE3

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

NCT00092872 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects

NCT06953063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease

NCT05517564 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)

NCT00642993 ·Status: COMPLETED ·Phase: PHASE2

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

NCT00735683 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ·Status: COMPLETED ·Phase: PHASE2

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

NCT00483171 ·Status: TERMINATED ·Phase: PHASE3

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet

NCT00747929 ·Status: COMPLETED ·Phase: PHASE2